{"id":"W2753841357","doi":"10.1093/annonc/mdx514","title":"Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab","year":2017,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Ramucirumab; Medicine; Placebo; Oncology; Monoclonal antibody; Internal medicine; Randomized controlled trial; Bevacizumab; Monoclonal; VEGF receptors; Antibody; Chemotherapy; Immunology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01294994,0.002624144,0.01199703,0.001860558,0.0004226906,0.002174263,0.00144268,0.001427886,0.003872193],"category_scores_gemma":[0.02792829,0.00119228,0.02980827,0.002608669,0.0005435731,0.001278611,0.001100742,0.002532181,0.0003878444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001404424,"about_ca_system_score_gemma":0.001196991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002351288,"about_ca_topic_score_gemma":0.005395302,"domain_scores_codex":[0.990356,0.005495681,0.002203397,0.0009560896,0.0007328361,0.00025615],"domain_scores_gemma":[0.9864275,0.01045587,0.00164426,0.0007494613,0.0005653285,0.0001575759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01432028,0.00003547954,0.00214891,0.05259015,0.9211248,0.00007065337,0.00003513492,0.0006070585,0.000304281,0.0001213579,0.0004498546,0.008191984],"study_design_scores_gemma":[0.003786176,0.0003512414,0.002602455,0.001601435,0.9900317,0.00005418338,0.00001709035,0.0001814141,0.0001272021,0.0002177595,0.001013233,0.00001616648],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03782714,0.9559166,0.002633744,0.0003266449,0.0004886736,0.0004693759,0.00136517,0.00008869316,0.0008838977],"genre_scores_gemma":[0.6725218,0.3162552,0.004528753,0.001541173,0.0003957691,0.0009073045,0.002427906,0.0001011128,0.001320985],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01294994,"threshold_uncertainty_score":0.06848669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5467726718018913,"score_gpt":0.5184122577197179,"score_spread":0.02836041408217338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}